case_images: PMC4899640_01
case_images: Intra- and subretinal edema and hyperreflectance due to tissue disruption in the laser spot area.
case_images: cop-0007-0130-g01.jpg
case_images: PMC4899640_01_cop-0007-0130-g01.jpg
case_images: F1
case_images: OCT demonstrated intra- and subretinal edema as well as tissue disruption within the injured area (fig. 1).
case_images: Hemorrhage around the spot and the Ozurdex implant on fundus examination.
case_images: cop-0007-0130-g02.jpg
case_images: PMC4899640_01_cop-0007-0130-g02.jpg
case_images: F2
case_images: One month after the injection, BCVA was 20/30 despite a hemorrhage around the injured area on fundus examination (fig. 2).
case_images: OCT image shows hyperreflectance scar in the affected region at the second month after Ozurdex implantation.
case_images: cop-0007-0130-g03.jpg
case_images: PMC4899640_01_cop-0007-0130-g03.jpg
case_images: F3
case_images: OCT showed decreased macular edema and a hyperreflectance scar in the affected area (fig. 3, fig. 4).